Medicine recalls
|
| |
| Batch recall of Akynzeo Concentrate for Solution for Infusion 235mg/0.25mg in 20ml |
| |
The Department of Health (DH) today (6 February) endorsed a licensed drug wholesaler, namely Pharmason Company Limited (Pharmason), distributor appointed by the holder of certificate of drug registration, Fosun Industrial Co., Limited (Fosun Industrial), to recall one batch (batch number: 43001977) of Akynzeo Concentrate for Solution for Infusion 235mg/0.25mg in 20ml (Hong Kong Registration number: HK- 67828), from the market as a precautionary measure due to potential quality issue.
The DH received notification from Fosun Industrial that the overseas manufacturer of the product is recalling the above batch due to stability test of retained sample showing out of specification assay result. As a precautionary measure, Fosun Industrial voluntarily recalls the above batch from the market.
The above product, containing fosnetupitant and palonosetron, is a prescription medicine indicated for the prevention of nausea and vomiting associated with chemotherapy. According to Fosun Industrial, the above batch of product was imported into Hong Kong and distributed by Pharmason and has been supplied to the Hospital Authority, local private hospitals and private doctors.
Fosun Industrial has set up a hotline (2509 2568) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above batch of product. The DH will closely monitor the recall.
Patients who have used the above product should consult their healthcare professionals if in doubt.
End/Thursday, February 6, 2025
|
| |
